期刊文献+

ⅢA—N2期非小细胞肺癌根治性切除术后的复发分析 被引量:5

Analysis of recurrence patterns after curative resection of stage ⅢA-N2 non-small cell lung cancer
原文传递
导出
摘要 目的探讨ⅢA.N2期非小细胞肺癌(NSCLC)患者根治术后肿瘤的复发情况及其相关影响因素。方法回顾北京大学第一医院2004年9月至2008年12月期间行肺癌根治术,并经病理证实为ⅢA,N2期的63例NSCLC患者的临床资料,随访监测肿瘤复发情况,Kaplan—Meier法计算术后复发率,应用Cox比例风险回归模型分析复发影响因素。结果63例患者术后2年和3年复发率分别为46.6%和57.3%,其中主要以转移性复发为主(27/28),局部复发仅1例;Cox单因素回归分析表明肿瘤组织中有淋巴血管侵犯(LVl)术后复发风险是LVI阴性者的2.54倍;N2阳性淋巴结数量〉3者的复发风险是淋巴结数1~3者的2.48倍;N2多站淋巴结转移者术后复发是N2单站淋巴结转移者的3.34倍;隆突下淋巴结转移者术后复发风险是未转移者的2.11倍。结论ⅢA—N2期NSCLC患者主要以转移性复发为主,影响术后复发的重要危险因素包括Lvl、N2阳性淋巴结站数、N2阳性淋巴结数量和隆突下淋巴结是否转移。 Objective To explore the postoperative recurrence patterns in the patients undergoing potentially curative resection of stage Ⅲ A-N2 non-small cell lung cancer (NSCLC). Methods A total of 63 patients underwent curative operation from September 2004 to December 2008 at Peking University First Hospital and were pathologically diagnosed as stage ⅢA-N2 NSCLC. Their clinical data were retrospectively reviewed. The follow-ups were conducted to detect the recurrent lesions. The recurrence rates at Year 2 -3 were calculated by the Kaplan-Meier method while the Cox proportional hazard model was used to assess the risk factors associated with recurrence. Results The 2 and 3-year recurrence rate was 46. 6% and 57. 3% respectively. Only one patient experienced local failure. However, the predominant recurrence pattern was distant failure (27/28). As demonstrated by the univariate Cox regression analysis, 4 significant factors associated with recurrence and the arm of lymphatic or vascular invasion ( LVI ) , number of positive N2 station 〉 1, number of positive node 〉 3 and involvement of subcarinal lymph nodes were found to increase the risks of failure ( P 〈 0. 05 ). Conclusion Distant failure is the predominant pattern of postoperative recurrence in the patients of stage ⅢA-N2 NSCLC. In addition to LVI, the level of positive N2 station, the number of positive N2 node and the involvement of subcarinal lymph nodes are associated with the postoperative risk of recurrence.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第33期2314-2318,共5页 National Medical Journal of China
关键词 非小细胞肺 纵隔 复发 Carcinoma, non-small-cell lung Mediastinum Recurrence
  • 相关文献

参考文献16

  • 1Robinson LA, Ruckdeschel JC, Wagner H Jr, et al. Treatment of non-small cell lung cancer-stage m A: ACCP evidence-basedclinical practice guidelines ( 2nd edition ). Chest, 2007, 132 : 243S-265S.
  • 2Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging project : proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol, 2009,9 : 1049-1059.
  • 3Trodella L, Granone P, Valente S, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I : definitive results of a phase 11I randomized trial. Radiother Oncol, 2002, 62:11-19.
  • 4Varlotto JM, Medford-Davis LN, Recht A, et al. Failure rates and patterns of recurrence in patients with resected N1 non-small- cell lung cancer. Int J Radiat Oncol Biol Phys, 2011, 81:353- 359.
  • 5Varlotto JM, Recht A, Flickinger JC, et al. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer, 2010, 116 : 2390 -2400.
  • 6van Meerbeeck JP, Surmont VF. Stage mA-N2 NSCLC: a review of its treatment approaches and future developments. Lung Cancer, 2009, 65:257-267.
  • 7Fujimoto T, Cassivi SD, Yang P, et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long- term survival. J Thorac Cardiovasc Surg, 2006, 132:499-506.
  • 8Boyd JA, Hubbs JL, Kim DW, et al. Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure. J Thorac Oncol, 2010, 5:211-214.
  • 9Kim ES, Lee IJ, Bae YA, et al. Evaluation of factors relating to tumor recurrence and survival after resection of lung cancer. Acta Radiol, 2009, 50:876-883.
  • 10Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer, 2009, 115:5218-5227.

二级参考文献10

  • 1Varlotto JM,,Recht A,Flickinger JC,et al.Factors associated with local and distant recurrence and survival in patients with resected non small cell lung cancer[].Cancer.2009
  • 2Matsuguma,,Rie NH,Yoshinori IK,et al.Postoperative radiotherapy for patients with completely resected pathological stage IIIA(N2)non-small cell lung cancer:focusing on an effect of the number of mediastinal lymph node stations involved[].Interactive Cardio Vascular and Thoracic Surgery.2008
  • 3Dautzenberg B,Arriagada R,Chammard AB,et al.A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma[].Cancer.1999
  • 4Montain CF,Dresler CM.Revision in the International System for Staging Lung Cancer[].Chest.1997
  • 5The International Adjuvant Lung Cancer Trial Collaborative Group.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[].New England Journal of Homeopathy.2004
  • 6Winton TL,Livingston R,Johnson D,et al.Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[].New England Journal of Medicine The.2005
  • 7Martini N,Bains M S,Burt M E,et al.Incidence of local recurrence and second primary tumors in resected stage I lung cancer[].Journal of Thoracic Imaging.1995
  • 8Casali,C.,Stefani,A.,Natali,P.Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases[].European Journal of Cardio Thoracic Surgery.2005
  • 9Saito M,Kato H.Prognostic factors in patients with pathological and N2 non-small cell lung cancer[].Annals of Thoracic and Cardiovascular Surgery.2008
  • 10Paulson DL,Reisch JS.Long-term survival after resection for bronchogenic carcinoma[].Annals of Surgery.1976

共引文献7

同被引文献41

  • 1孙英民.肺癌手术中大出血51例的紧急处理[J].中国误诊学杂志,2006,6(3):444-445. 被引量:2
  • 2窦学军,刘树库,陈肖嘉,白连启,许绍发,闫东杰,龚昌帆.外科治疗III_A期N_2非小细胞肺癌的预后分析及临床意义[J].中华胸心血管外科杂志,2006,22(2):105-107. 被引量:18
  • 3Joseph Awad,Amir Owrangi,Lauren Villemaire,et al. Three-dimensional lung tumor segmentation from x-ray computed tomography using sparse field active models[J]. Medical Physics, 2012,39 (2) :851-65.
  • 4Helena Wensman,Nona Kamgari,Anna Johansson,et al. Tumor-mast cell interactions: Induction of pro-tumori- genic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma[J]. Molecular Immunolo- gy,2012,50(4):210-219.
  • 5Chen YF, Li YC,Chen L. Primary cutaneous diffuse large B cell lymphoma relapsed solely as a huge lung tumor mimicking a primary pulmonary lymphoma[J]. International Journal of Hematology ,2010,91 ( 1 ):112-116.
  • 6P David, Mozley Claus, Bendtsen Binsheng Zhao,et al. Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer[J]. Translational Ontology ,2012,5( 1 ):19-25.
  • 7祝鑫海,毛伟敏.胸外科手术并发大出血的原因分析与治疗[J].肿瘤学杂志,2007,13(6):440-441. 被引量:8
  • 8Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study [ J ]. Lung Cancer, 2005,50 : 227 -234.
  • 9Detterbeck FC, Boffa DJ ,Tanoue LT. The new lung cancer staging system[J]. Chest,2009 , 136:260-271.
  • 10Vallieres E, Shepherd FA, Crewley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming ( seventh ) edition of the TNM classification for lung cancer[ J]. J Thorac Oncol, 2009, 4 : 1049-1059.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部